<--- Back to Details
First PageDocument Content
Food and Drug Administration / Clinical pharmacology / Pharmacology / Therapeutics / United States Public Health Service / Nanotechnology / Medical device / Dietary supplement / Regulation of nanotechnology / Medicine / Health / Technology
Date: 2013-10-09 09:43:38
Food and Drug Administration
Clinical pharmacology
Pharmacology
Therapeutics
United States Public Health Service
Nanotechnology
Medical device
Dietary supplement
Regulation of nanotechnology
Medicine
Health
Technology

Microsoft PowerPoint - Canady EC First Annual SFS final.ppt

Add to Reading List

Source URL: ec.europa.eu

Download Document from Source Website

File Size: 258,18 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xvUb - View Document

PDF Document

DocID: 1xc8R - View Document

Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME

DocID: 1vqsj - View Document

Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia

DocID: 1vlJU - View Document

Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology

DocID: 1vk1K - View Document